Page last updated: 2024-08-23

diltiazem and Colorectal Neoplasms

diltiazem has been researched along with Colorectal Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Boldig, K; Ganguly, A; Kadakia, M; Rohatgi, A1
Ambrosy, AP; Fisher, GA; Kunz, PL; Witteles, RM1
Abu-Arafeh, A; Campbell, RT; Dalzell, JR1

Other Studies

3 other study(ies) available for diltiazem and Colorectal Neoplasms

ArticleYear
Managing life-threatening 5-fluorouracil cardiotoxicity.
    BMJ case reports, 2022, Oct-17, Volume: 15, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Calcium Channel Blockers; Camptothecin; Cardiotoxicity; Cardiotoxins; Colorectal Neoplasms; Coronary Vasospasm; Diltiazem; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Nitrates

2022
Capecitabine-induced chest pain relieved by diltiazem.
    The American journal of cardiology, 2012, Dec-01, Volume: 110, Issue:11

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Anus Neoplasms; Calcium Channel Blockers; Capecitabine; Carcinoma, Squamous Cell; Chest Pain; Colorectal Neoplasms; Coronary Vasospasm; Deoxycytidine; Diltiazem; Electrocardiography; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prodrugs; Secondary Prevention; Treatment Outcome

2012
Cardiotoxicity with 5-fluorouracil based agents: rechallenge cannot currently be safely advised.
    The American journal of cardiology, 2013, Feb-01, Volume: 111, Issue:3

    Topics: Chest Pain; Colorectal Neoplasms; Deoxycytidine; Diltiazem; Female; Fluorouracil; Humans; Male

2013